NextCell Pharma AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is September - August.

Millions EUR. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 4, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	2020 - 2016
Market Capitalization	7	12	8	10	20	49	Upgrade
Market Cap Growth	-31.16%	43.77%	-21.57%	-48.86%	-58.29%	104.37%	Upgrade
Enterprise Value	4	10	6	5	10	34	Upgrade
Last Close Price	0.05	0.09	0.07	0.29	0.59	1.41	Upgrade
PS Ratio	7.48	11.78	8.23	8.87	35.05	111.90	Upgrade
PB Ratio	1.25	1.96	1.37	1.63	1.89	3.32	Upgrade
P/TBV Ratio	1.25	1.96	1.37	1.63	1.89	3.32	Upgrade
EV/Sales Ratio	3.90	10.27	6.39	4.34	17.86	78.06	Upgrade
Asset Turnover	0.14	0.14	0.13	0.13	0.04	0.05	Upgrade
Inventory Turnover	17.24	17.24	22.79	14.12	-	-	Upgrade
Quick Ratio	8.05	8.05	5.06	5.32	14.40	35.60	Upgrade
Current Ratio	10.02	10.02	6.15	6.67	15.40	37.02	Upgrade
Return on Equity (ROE)	-52.46%	-52.46%	-58.55%	-41.63%	-26.02%	-27.86%	Upgrade
Return on Assets (ROA)	-28.39%	-28.39%	-31.72%	-24.01%	-15.62%	-16.73%	Upgrade
Return on Capital (ROIC)	-33.48%	-33.48%	-37.65%	-26.80%	-16.48%	-17.60%	Upgrade
Return on Capital Employed (ROCE)	-50.30%	-50.30%	-60.50%	-52.10%	-29.80%	-16.40%	Upgrade
Earnings Yield	-42.43%	-26.96%	-45.20%	-32.17%	-15.83%	-4.93%	Upgrade
FCF Yield	-51.98%	-33.03%	-40.79%	-38.72%	-18.74%	-5.28%	Upgrade
Buyback Yield / Dilution	-87.22%	-87.22%	-18.72%	-	-13.05%	-53.09%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.